Myriad Genetics buy Raymond James
Start price
07.05.25
/
50%
€4.12
Target price
07.05.26
€8.82
Performance (%)
-7.77%
Price
16.02.26
€3.74
Summary
This prediction is currently active. With a performance of -7.77%, the BUY prediction for Myriad Genetics by Raymond_James is down slightly. This prediction currently runs until 07.05.26. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Myriad Genetics | -12.617% | -12.617% |
| iShares Core DAX® | -0.821% | -2.027% |
| iShares Nasdaq 100 | -1.743% | -5.354% |
| iShares Nikkei 225® | 1.215% | 6.383% |
| iShares S&P 500 | -1.167% | -3.462% |
Comments by Raymond_James for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $10.00 price target on the stock, down previously from $19.00.
Ratings data for MYGN provided by MarketBeat